Real-world evidence of axicabtagene ciloleucel (Axi-cel) for the treatment of large B-cell lymphoma (LBCL) in the United States (US) Meeting Abstract
| Authors: | Jacobson, C. A.; Locke, F. L.; Hu, Z. H.; Siddiqi, T.; Ahmed, S.; Ghobadi, A.; Miklos, D. B.; Lin, Y.; Perales, M. A.; Lunning, M. A.; Herr, M.; Hill, B. T.; Ganguly, S.; Dong, H.; Nikiforow, S.; Xie, J.; Xu, H.; Hooper, M.; Kawashima, J.; Pasquini, M. C. |
| Abstract Title: | Real-world evidence of axicabtagene ciloleucel (Axi-cel) for the treatment of large B-cell lymphoma (LBCL) in the United States (US) |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120604149 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.7552 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 7552 -- Source: Wos |
